Skip to content

Contact +44 (0) 20 7060 7474 email us

Allergy / Colds

Cough, Cold and Allergy (Hay Fever) Remedies in Italy

 

Publication Date March 2009
Publisher Euromonitor International
Product Type Report
Pages 59
ISBN Number not applicable
Product Code EUR00729

Price

£560.00
approximately: $848 | €625

pdf immediate delivery

Buy Now

print

Buy Now

Order above formats by FAX

Order by Fax

Summary

Euromonitor International's Cough, Cold and Allergy Products in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the cough, cold and allergy (hayfever) industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

  • Cough, Cold and Allergy (hay Fever) Remedies in Italy
  • Euromonitor International
  • March 2009
  • Executive Summary
  • A Positive Result Driven by Price Liberalisation
  • the Weak Effects of Deregulation
  • A Fragmented Market Led by Bayer
  • Chemists/pharmacies Remain the Undisputed Leaders
  • Vitamins and Dietary Supplements Will Be Growth Driver
  • Key Trends and Developments
  • A Very Old Country
  • What Price? the Effects of Price Liberalisation
  • the Results of the New Bersani Law
  • Are Parapharmacies/drugstores True Competitors?
  • the Need for A Healthier Lifestyle
  • Pharmaclick - A New Distributor?
  • Market Data
  • $1OTC Registration and Classification
  • De-listing Or De-reimbursement
  • Advertising
  • Packaging and Waste
  • Labelling
  • Distribution
  • Vitamins and Dietary Supplements Registration and Classification
  • EU Legislation
  • Self-medication and Preventive Medicine
  • Generics
  • Switches
  • Definitions
  • Sources
  • A Menarini Industrie Farmaceutiche Riunite SRL
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Aziende Chimiche Riunite Angelini Francesco Acraf SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Bayer SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Bracco SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Chiesi Farmaceutici SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Perfetti Van Melle SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Recordati Industria Chimica E Farmaceutica SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Sanofi-aventis SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Sigma-tau Industrie Farmaceutiche Riunite SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Zambon Italia SpA
  • Strategic Direction
  • Key Facts
  • Company Background
  • Production
  • Competitive Positioning
  • Headlines
  • Trends
  • Switches
  • Competitive Landscape
  • Prospects
  • Sector Data
  • List of Summaries
    • Summary 1 OTC Healthcare Switches 2005-2007
    • Summary 2 Research Sources
    • Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
    • Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
    • Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2008
    • Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
    • Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
    • Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2007
    • Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2008
    • Summary 10 Bayer SpA: Key Facts
    • Summary 11 Bayer SpA: Operational Indicators
    • Summary 12 Bayer SpA: Competitive Position 2008
    • Summary 13 Bracco SpA: Key Facts
    • Summary 14 Bracco SpA: Operational Indicators
    • Summary 15 Bracco SpA: Competitive Position 2008
    • Summary 16 Chiesi Farmaceutici SpA: Key Facts
    • Summary 17 Chiesi Farmaceutici SpA: Operational Indicators
    • Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2008
    • Summary 19 Perfetti Van Melle SpA: Key Facts
    • Summary 20 Perfetti Van Melle SpA: Operational Indicators
    • Summary 21 Perfetti Van Melle SpA: Competitive Position 2008
    • Summary 22 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
    • Summary 23 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
    • Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2007
    • Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2008
    • Summary 26 Sanofi-Aventis SpA: Key Facts
    • Summary 27 Sanofi-Aventis SpA: Operational Indicators
    • Summary 28 Sanofi-Aventis SpA: Competitive Position 2008
    • Summary 29 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
    • Summary 30 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
    • Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2008
    • Summary 32 Zambon Italia SpA: Key Facts
    • Summary 33 Zambon Italia SpA: Operational Indicators
    • Summary 34 Zambon Italia SpA: Production Statistics 2007
    • Summary 35 Zambon Italia SpA: Competitive Position 2008
  • List of Tables
    • Table 1 Sales of OTC Healthcare by Sector: Value 2003-2008
    • Table 2 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
    • Table 3 OTC Healthcare Company Shares by Value 2004-2008
    • Table 4 OTC Healthcare Brand Shares by Value 2005-2008
    • Table 5 Penetration of Private Label by Sector 2003-2008
    • Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
    • Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
    • Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
    • Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
    • Table 10 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
    • Table 11 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
    • Table 12 Sales of Decongestants by Type: Value 2003-2008
    • Table 13 Sales of Decongestants by Type: % Value Growth 2003-2008
    • Table 14 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
    • Table 15 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
    • Table 16 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
    • Table 17 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
    • Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
    • Table 19 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
    • Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013